Efficacy and Safety of Saxagliptin in Combination With Insulin in Elderly Patients With Type 2 Diabetes

被引：0
|
作者：
Charbonnel, Bernard
Barnett, Anthony H.
Monyak, John
Minervini, Gianmaria
Iqbal, Nayyar
机构：
来源：
DIABETES | 2012年 / 61卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1048-P
引用
收藏
页码：A269 / A269
页数：1
相关论文
共 50 条
  • [31] Efficacy and safety of a combination of miglitol, metformin and insulin aspart in the treatment of type 2 diabetes
    Ke, Tingyu
    Cheng, Guoliang
    Tan, Liping
    Zhou, Xiangming
    Miao, Yuanyuan
    Du, Shigang
    Wang, Jia
    Pan, Yi
    Bi, Jingjie
    Zhao, Lin
    Zhi, Yunxia
    Zhao, Ling
    TROPICAL JOURNAL OF PHARMACEUTICAL RESEARCH, 2021, 20 (10) : 2171 - 2177
  • [32] Long-Term Efficacy and Safety of Saxagliptin in a Triple-Therapy Regimen With Insulin and Metformin for Type 2 Diabetes
    Charbonnel, Bernard
    Barnett, Anthony H.
    Monyak, John
    Minervini, Gianmaria
    Iqbal, Nayyar
    DIABETES, 2012, 61 : A292 - A292
  • [33] Efficacy and Safety of Evogliptin plus Metformin Added to Insulin Therapy in Elderly Indian Patients with Type 2 Diabetes
    Guha, Shaibal
    Ranjan, Rajeev
    Gaurav, Amit
    Ranjan, Prakash
    DIABETES, 2021, 70
  • [34] Long-term efficacy and safety of canagliflozin in combination with insulin in Japanese patients with type 2 diabetes mellitus
    Inagaki, Nobuya
    Harashima, Shin-ichi
    Kaku, Kohei
    Kondo, Kazuoki
    Maruyama, Nobuko
    Otsuka, Makiko
    Kawaguchi, Yutaka
    Iijima, Hiroaki
    DIABETES OBESITY & METABOLISM, 2018, 20 (04): : 812 - 820
  • [35] Efficacy and safety of imeglimin in combination with insulin in Japanese patients with type 2 diabetes: results of TIMES 3 trial
    Dubourg, J.
    Watada, H.
    Thang, C.
    Kaneko, T.
    Fouqueray, P.
    DIABETOLOGIA, 2020, 63 (SUPPL 1) : S307 - S307
  • [36] Effectiveness and Safety of Human Insulin Treatment in Elderly Patients with Type 2 Diabetes
    Dzida, Grzegorz J.
    Pasterczyk-Bielska, Katarzyna
    Masierek, Malgorzata
    DIABETES, 2024, 73
  • [37] Long-Term Safety and Tolerability of Saxagliptin Add-On Therapy in Elderly Patients With Type 2 Diabetes
    Iqbal, Nayyar
    Allen, Elsie
    Donovan, Mark
    Ohman, Peter
    DIABETES, 2012, 61 : A299 - A299
  • [38] Efficacy and tolerability of saxagliptin compared with glimepiride in elderly patients with type 2 diabetes: a randomized, controlled study (GENERATION)
    Schernthaner, G.
    Duran-Garcia, S.
    Hanefeld, M.
    Langslet, G.
    Niskanen, L.
    Ostgren, C. J.
    Malvolti, E.
    Hardy, E.
    DIABETES OBESITY & METABOLISM, 2015, 17 (07): : 630 - 638
  • [39] Saxagliptin plus metformin combination in patients with type 2 diabetes and renal impairment
    Scheen, Andre J.
    EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY, 2012, 8 (03) : 383 - 394
  • [40] Efficacy and Safety of Linagliptin in Elderly Patients (≥ 70 Years) With Type 2 Diabetes
    Barnett, Anthony
    Huisman, Holger
    Jones, Russell
    Von Eynatten, Maximilian
    Patel, Sanjay
    Woerle, Hans-Juergen
    DIABETES, 2012, 61 : A260 - A261
12345